prednisolone has been researched along with Macrophage Activation Syndrome in 13 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Macrophage Activation Syndrome: A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a multi-center cohort study of children in Turkish Pediatric Intensive Care units with hyperferritinemia associated secondary HLH/sepsis/MODS/MAS treated with less immunosuppression (plasma exchange and intravenous immunoglobulin or methyl prednisolone) or with the primary HLH protocol (plasma exchange and dexamethasone or cyclosporine A and/or etoposide)." | 3.78 | Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? ( Bayrakci, B; Carcillo, JA; Citak, A; Demirkol, D; Dursun, O; Erkek, N; Gedik, H; Karabocuoglu, M; Karapinar, B; Kendirli, T; Kesici, S; Koroglu, TF; Yildizdas, D, 2012) |
| "Thrombocytopenia was seen in 11 patients." | 1.62 | Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India. ( Gupta, A; Jindal, AK; Johnson, N; Pilania, RK; Prithvi, A; Rawat, A; Singh, S; Suri, D; Vignesh, P, 2021) |
| "We describe 2 patients with systemic juvenile idiopathic arthritis and macrophage activation syndrome." | 1.37 | Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. ( Bruck, N; Gahr, M; Heubner, G; Kabus, M; Pessler, F; Suttorp, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, T | 1 |
| Ooka, S | 1 |
| Mizushima, M | 1 |
| Nakamura, Y | 1 |
| Ikeda, H | 1 |
| Sakurada, T | 1 |
| Suzuki, S | 1 |
| Yamazaki, K | 1 |
| Goto, Y | 1 |
| Sakurai, K | 1 |
| Yukitaka, Y | 1 |
| Kiyokawa, T | 1 |
| Tonooka, K | 1 |
| Kunishima, H | 1 |
| Kawahata, K | 1 |
| Horiuchi, Y | 1 |
| Hashimoto, K | 1 |
| Horikoshi, H | 1 |
| Sano, A | 1 |
| Kawamura, Y | 1 |
| Fujita, N | 1 |
| Kimata, M | 1 |
| Ono, Y | 1 |
| Obuchi, Y | 1 |
| Makino, A | 1 |
| Kaneko, M | 1 |
| Kimura, F | 1 |
| Itoh, K | 1 |
| Tanaka, Y | 1 |
| Goda, K | 1 |
| Kenzaka, T | 1 |
| Hoshijima, M | 1 |
| Yachie, A | 3 |
| Akita, H | 1 |
| Shah, K | 1 |
| Porter, A | 1 |
| Takhar, G | 1 |
| Reddy, V | 1 |
| Pilania, RK | 1 |
| Jindal, AK | 2 |
| Johnson, N | 1 |
| Prithvi, A | 1 |
| Vignesh, P | 1 |
| Suri, D | 2 |
| Rawat, A | 1 |
| Gupta, A | 1 |
| Singh, S | 1 |
| Tulbă, D | 1 |
| Balea, M | 1 |
| Băicuş, C | 1 |
| Aoyama-Maeda, N | 1 |
| Horino, T | 1 |
| Ichii, O | 1 |
| Terada, Y | 1 |
| Agarwal, A | 1 |
| Guleria, S | 1 |
| Singh, MP | 1 |
| Sharma, S | 1 |
| Naseem, S | 1 |
| Ratho, RK | 1 |
| Shimizu, M | 2 |
| Kizawa, T | 1 |
| Kato, R | 1 |
| Suzuki, T | 1 |
| Inoue, N | 1 |
| Tsunoda, S | 1 |
| Kawano, M | 1 |
| Matsumura, M | 1 |
| Bruck, N | 1 |
| Suttorp, M | 1 |
| Kabus, M | 1 |
| Heubner, G | 1 |
| Gahr, M | 1 |
| Pessler, F | 1 |
| John, TM | 1 |
| Jacob, CN | 1 |
| Ittycheria, CC | 1 |
| George, AM | 1 |
| Jacob, AG | 1 |
| Subramaniyam, S | 1 |
| Puthiyaveettil, J | 1 |
| Jayaprakash, R | 1 |
| Demirkol, D | 1 |
| Yildizdas, D | 1 |
| Bayrakci, B | 1 |
| Karapinar, B | 1 |
| Kendirli, T | 1 |
| Koroglu, TF | 1 |
| Dursun, O | 1 |
| Erkek, N | 1 |
| Gedik, H | 1 |
| Citak, A | 1 |
| Kesici, S | 1 |
| Karabocuoglu, M | 1 |
| Carcillo, JA | 1 |
1 review available for prednisolone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
Topics: Cytokines; Female; Glucocorticoids; Humans; Interleukin-18; Interleukin-6; Macrophage Activation Syn | 2020 |
12 other studies available for prednisolone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; COVID-19 Drug Treatment; Ferritins; Humans; Macr | 2022 |
Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Disseminated Intravascular Coagul | 2022 |
Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glucocorticoid | 2020 |
Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Topics: Child; Child, Preschool; Coronary Aneurysm; Female; Glucocorticoids; Humans; Immunoglobulins, Intrav | 2021 |
Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
Topics: Adult; Diagnosis, Differential; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; | 2018 |
Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobu | 2018 |
Adult-Onset Still Disease and Macrophage Activation Syndrome Following Chikungunya and Hepatitis E Coinfection.
Topics: Adolescent; Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Female; Hepatitis E; Hepatit | 2018 |
Macrophage activation syndrome in neonates born to mothers with adult-onset Still's disease: Perinatal effect of maternal IL-18.
Topics: Adult; Blood Transfusion; Dexamethasone; Female; Ferritins; Glucocorticoids; Humans; Infant, Newborn | 2019 |
Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Juvenile; Child; Child, Prescho | 2016 |
Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Dexamethasone; Drug Tolerance; Female; Glucocortic | 2011 |
Macrophage activation syndrome following Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Colistin; Cyclospor | 2012 |
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Combined Modality Therapy; C | 2012 |